# UroX Biomarker Bladder Cancer Study

> **NCT03973307** · — · UNKNOWN · sponsor: **East and North Hertfordshire NHS Trust** · enrollment: 100 (estimated)

## Conditions studied

- Bladder Cancer

## Interventions

- **DIAGNOSTIC_TEST:** UroX bladder cancer biomarker test

## Key facts

- **NCT ID:** NCT03973307
- **Lead sponsor:** East and North Hertfordshire NHS Trust
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-21
- **Primary completion:** 2020-07-01
- **Final completion:** 2025-07-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2019-06-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03973307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03973307, "UroX Biomarker Bladder Cancer Study". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03973307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
